LeMaitre Vascular Inc
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arte… Read more
LeMaitre Vascular Inc (LMAT) - Net Assets
Latest net assets as of September 2025: $378.92 Million USD
Based on the latest financial reports, LeMaitre Vascular Inc (LMAT) has net assets worth $378.92 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($598.07 Million) and total liabilities ($219.15 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $378.92 Million |
| % of Total Assets | 63.36% |
| Annual Growth Rate | 18.26% |
| 5-Year Change | 95.45% |
| 10-Year Change | 333.07% |
| Growth Volatility | 37.78 |
LeMaitre Vascular Inc - Net Assets Trend (2001–2024)
This chart illustrates how LeMaitre Vascular Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LeMaitre Vascular Inc (2001–2024)
The table below shows the annual net assets of LeMaitre Vascular Inc from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $337.29 Million | +13.22% |
| 2023-12-31 | $297.90 Million | +11.07% |
| 2022-12-31 | $268.20 Million | +5.53% |
| 2021-12-31 | $254.15 Million | +47.27% |
| 2020-12-31 | $172.57 Million | +16.49% |
| 2019-12-31 | $148.14 Million | +13.75% |
| 2018-12-31 | $130.24 Million | +18.64% |
| 2017-12-31 | $109.77 Million | +25.45% |
| 2016-12-31 | $87.50 Million | +12.35% |
| 2015-12-31 | $77.88 Million | +14.19% |
| 2014-12-31 | $68.21 Million | +20.59% |
| 2013-12-31 | $56.56 Million | +6.95% |
| 2012-12-31 | $52.89 Million | +1.54% |
| 2011-12-31 | $52.09 Million | -0.51% |
| 2010-12-31 | $52.36 Million | +8.59% |
| 2009-12-31 | $48.21 Million | +5.39% |
| 2008-12-31 | $45.75 Million | -5.84% |
| 2007-12-31 | $48.59 Million | -4.17% |
| 2006-12-31 | $50.70 Million | +173.52% |
| 2005-12-31 | $18.54 Million | +25.13% |
| 2004-12-31 | $14.81 Million | +84.61% |
| 2002-12-31 | $8.02 Million | +12.73% |
| 2001-12-31 | $7.12 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to LeMaitre Vascular Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 14509000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $145.09 Million | 43.02% |
| Common Stock | $242.00K | 0.07% |
| Other Comprehensive Income | $-6.18 Million | -1.83% |
| Other Components | $198.14 Million | 58.75% |
| Total Equity | $337.29 Million | 100.00% |
LeMaitre Vascular Inc Competitors by Market Cap
The table below lists competitors of LeMaitre Vascular Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Iida Group Holdings Co. Ltd
STU:IIO
|
$1.99 Billion |
|
Downer EDI Limited
PINK:DNERF
|
$1.99 Billion |
|
Balkrishna Industries Limited
NSE:BALKRISIND
|
$1.99 Billion |
|
Metcash Ltd
AU:MTS
|
$1.99 Billion |
|
Huron Consulting Group Inc
NASDAQ:HURN
|
$1.99 Billion |
|
Xiamen C&D Inc
SHG:600153
|
$1.99 Billion |
|
Hubei Energy Group Co Ltd
SHE:000883
|
$1.99 Billion |
|
Western Metal Materials Co Ltd
SHE:002149
|
$1.99 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LeMaitre Vascular Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 297,900,000 to 337,290,000, a change of 39,390,000 (13.2%).
- Net income of 44,038,000 contributed positively to equity growth.
- Dividend payments of 14,378,000 reduced retained earnings.
- Share repurchases of 1,719,000 reduced equity.
- New share issuances of 6,440,000 increased equity.
- Other comprehensive income decreased equity by 1,559,000.
- Other factors increased equity by 6,568,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $44.04 Million | +13.06% |
| Dividends Paid | $14.38 Million | -4.26% |
| Share Repurchases | $1.72 Million | -0.51% |
| Share Issuances | $6.44 Million | +1.91% |
| Other Comprehensive Income | $-1.56 Million | -0.46% |
| Other Changes | $6.57 Million | +1.95% |
| Total Change | $- | 13.22% |
Book Value vs Market Value Analysis
This analysis compares LeMaitre Vascular Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.58x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 469.92x to 7.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $0.24 | $112.23 | x |
| 2002-12-31 | $1.04 | $112.23 | x |
| 2004-12-31 | $1.77 | $112.23 | x |
| 2005-12-31 | $2.13 | $112.23 | x |
| 2006-12-31 | $5.12 | $112.23 | x |
| 2007-12-31 | $3.16 | $112.23 | x |
| 2008-12-31 | $2.94 | $112.23 | x |
| 2009-12-31 | $3.03 | $112.23 | x |
| 2010-12-31 | $3.25 | $112.23 | x |
| 2011-12-31 | $3.26 | $112.23 | x |
| 2012-12-31 | $3.38 | $112.23 | x |
| 2013-12-31 | $3.59 | $112.23 | x |
| 2014-12-31 | $4.01 | $112.23 | x |
| 2015-12-31 | $4.25 | $112.23 | x |
| 2016-12-31 | $4.55 | $112.23 | x |
| 2017-12-31 | $5.48 | $112.23 | x |
| 2018-12-31 | $6.43 | $112.23 | x |
| 2019-12-31 | $7.29 | $112.23 | x |
| 2020-12-31 | $8.43 | $112.23 | x |
| 2021-12-31 | $11.83 | $112.23 | x |
| 2022-12-31 | $12.10 | $112.23 | x |
| 2023-12-31 | $13.29 | $112.23 | x |
| 2024-12-31 | $14.81 | $112.23 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LeMaitre Vascular Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.06%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 20.03%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.64x
- Recent ROE (13.06%) is above the historical average (5.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | -35.38% | -4.82% | 1.03x | 7.11x | $-776.00K |
| 2002 | 6.02% | 2.78% | 1.37x | 1.58x | $-319.40K |
| 2004 | 6.26% | 3.54% | 1.28x | 1.38x | $-554.30K |
| 2005 | 0.30% | 0.18% | 1.23x | 1.35x | $-1.80 Million |
| 2006 | -2.31% | -3.38% | 0.61x | 1.12x | $-6.24 Million |
| 2007 | -6.04% | -7.08% | 0.68x | 1.26x | $-7.79 Million |
| 2008 | -7.24% | -6.80% | 0.90x | 1.19x | $-7.89 Million |
| 2009 | 3.31% | 3.14% | 0.89x | 1.18x | $-3.22 Million |
| 2010 | 11.48% | 10.73% | 0.89x | 1.21x | $777.40K |
| 2011 | 4.11% | 3.72% | 0.97x | 1.15x | $-3.07 Million |
| 2012 | 4.86% | 4.53% | 0.90x | 1.19x | $-2.72 Million |
| 2013 | 5.66% | 4.96% | 0.92x | 1.25x | $-2.45 Million |
| 2014 | 5.74% | 5.51% | 0.87x | 1.19x | $-2.91 Million |
| 2015 | 9.96% | 9.90% | 0.86x | 1.16x | $-30.40K |
| 2016 | 12.10% | 11.88% | 0.87x | 1.16x | $1.84 Million |
| 2017 | 15.65% | 17.03% | 0.80x | 1.15x | $6.20 Million |
| 2018 | 17.62% | 21.73% | 0.69x | 1.18x | $9.92 Million |
| 2019 | 12.11% | 15.30% | 0.62x | 1.27x | $3.12 Million |
| 2020 | 12.30% | 16.40% | 0.51x | 1.46x | $3.96 Million |
| 2021 | 10.59% | 17.42% | 0.53x | 1.15x | $1.49 Million |
| 2022 | 7.69% | 12.77% | 0.52x | 1.16x | $-6.18 Million |
| 2023 | 10.11% | 15.56% | 0.56x | 1.16x | $315.00K |
| 2024 | 13.06% | 20.03% | 0.40x | 1.64x | $10.31 Million |
Industry Comparison
This section compares LeMaitre Vascular Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LeMaitre Vascular Inc (LMAT) | $378.92 Million | -35.38% | 0.58x | $1.99 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |